Status:
COMPLETED
Study of Coagulation Activation Markers and Pre Eclampsia
Lead Sponsor:
University Hospital, Lille
Conditions:
Pre Eclampsia
Eligibility:
FEMALE
18-50 years
Brief Summary
The primary purpose of the trial is to evaluate coagulation activator markers in patients with pre eclampsia compared to control (normal pregnancy) and to correlate these markers with the severity of ...
Detailed Description
100 pre-eclamptic patients will be compared to 200 control patients (100 control matched on gestational age at inclusion and 100 control matched on delivery mode (section). Blood and urine samples wi...
Eligibility Criteria
Inclusion
- 18 years old
- diagnosis of pre eclampsia
Exclusion
- multiple pregnancy
- less than 18 year old
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01261351
Start Date
May 1 2010
End Date
June 1 2014
Last Update
December 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Lille
Lille, Nord, France, 59037